Clinical trials
Amyloid Neuropathies, Familial trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 6 |
| University Hospital, Essen | 5 |
| Pfizer | 4 |
| CENTOGENE GmbH Rostock | 2 |
| Heinrich-Heine University, Duesseldorf | 2 |
| Ionis Pharmaceuticals, Inc. | 2 |
| University of Leipzig | 2 |
| AstraZeneca | 1 |
| Charite University, Berlin, Germany | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloid Neuropathies, Familial | 28 |
| Amyloidosis | 15 |
| Alzheimer Disease | 7 |
| Polyneuropathies | 7 |
| Amyloid Neuropathies | 5 |
| Amyloidosis, Familial | 5 |
| Cardiomyopathies | 5 |
| Aortic Valve Stenosis | 3 |
| Heart Failure | 3 |
| Immunoglobulin Light-chain Amyloidosis | 2 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.